Adjuvant Radiotherapy in High Risk Locally Advanced DTC

This study is a phase III randomized controlled clinical trial on the role of adjuvant radiotherapy in high-risk locally advanced differentiated thyroid cancer. Patients who meet the inclusion criteria were randomly assigned 1:1 to either the experimental group (adjuvant radiotherapy+RAI) or the control group (RAI), with LRFS as the primary endpoint of the study.

Trial Details

NCT ID
NCT06558981
Phase
PHASE3
Sponsor
Fudan University
Status
RECRUITING
Cancer Type
Thyroid Cancer
Interventions
  • Radiotherapy
  • radioiodine treatment
Locations (sample)
  • Shanghai, China|31.22222,121.45806

Key Eligibility Criteria

  • The patient voluntarily joined this study and signed an informed consent form;
  • Age: ≥ 14 years old,\<80 years old, male or female not limited;
  • Histopathological diagnosis of differentiated thyroid cancer;
  • Surgical total or near total thyroidectomy;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Thyroid Cancer Trials on Trialify →